Who is responsible for 340B compliance: the TPA or the covered entity?
The covered entity. A 340B TPA can run eligibility logic, accumulators, replenishment orders, Medicaid filters and reporting for you, but it can’t take on the legal duty. The 340B statute puts the bans on diversion and duplicate discounts on the covered entity, makes the covered entity’s records subject to HRSA and manufacturer audits, and makes the covered entity liable to manufacturers when violations are found. HRSA’s contract pharmacy guidance says the same thing in plain words: the covered entity “retain[s] ultimate responsibility for compliance with the 340B program.” What you can do is choose a TPA whose work you can see, check and correct, and put that in the contract.[1][2]
The TPA runs the work. You own the result.
The guidance repeats it more than once
“The covered entity has, and continues to bear, full responsibility and accountability for compliance with all requirements to prevent diversion … and to prevent situations in which a drug is subject to both the 340B discount and a Medicaid Rebate claim.”
“The covered entity remains responsible at all times for the disposition of covered outpatient drugs it purchases through a contract pharmacy.”
“The covered entity bears responsibility for compliance with the program and will be held accountable in the event of non-compliance.”
The same notice also says HRSA leaves it up to covered entities to decide how to meet these responsibilities. That flexibility is why the choice of TPA, and the terms you sign with it, matter so much.[1]
Every 340B duty names the covered entity
The 340B statute never mentions a TPA. These are the provisions that matter most for day-to-day compliance.
- § 256b(a)(5)(A)No duplicate discounts
A covered entity shall not request Medicaid payment for a 340B drug that is also subject to a Medicaid rebate.[2]
- § 256b(a)(5)(B)No diversion
A covered entity shall not resell or otherwise transfer a 340B drug to a person who is not its patient.[2]
- § 256b(a)(5)(C)Open records
A covered entity shall let HRSA and manufacturers audit the entity’s records that pertain to those two requirements.[2]
- § 256b(a)(5)(D)Repayment
If HRSA finds a violation after audit, notice and hearing, the covered entity is liable to the manufacturer for the discount it received.[2]
- § 256b(d)(2)(B)(v)Removal
Diversion that is systematic and egregious as well as knowing and intentional can get a covered entity removed from the program and barred from re-entry for a period.[2]
Covered entity, TPA and contract pharmacy, task by task
“Owns” means accountable to HRSA. “Runs” means does the day-to-day work under your rules. “Supports” means provides data or help. Your contracts may divide the work differently, but the Owns column doesn’t move.
| Task | Covered entity | TPA | Contract pharmacy | Why |
|---|---|---|---|---|
| Registering sites and contract pharmacies in OPAIS; annual recertification | Owns | Supports | — | An authorized official of the covered entity certifies, including that contract pharmacy arrangements were performed as required.[1][3] |
| Written contract pharmacy agreement covering the essential elements | Owns | — | Supports | HRSA lists the elements (a)–(j) the agreement should address; the TPA is usually a separate contract.[1] |
| Patient eligibility rules (who counts as your patient) | Owns | Runs | Supports | Element (h): the covered entity and pharmacy develop a system to verify eligibility. A TPA typically applies the rules you set to each claim.[1] |
| Tracking system and prescribing-vs-dispensing comparisons | Owns | Runs | Supports | Element (g): a tracking system suitable to prevent diversion, plus periodic comparison of your prescribing records with dispensing records.[1] |
| Medicaid carve-in / carve-out decision and duplicate discount prevention | Owns | Runs | Supports | Element (i): no 340B drug for Medicaid prescriptions at a contract pharmacy unless an arrangement with the state is in place and reported to HRSA.[1][2] |
| Purchasing, title and price of 340B drugs (ship-to, bill-to) | Owns | Supports | Supports | Element (a): the covered entity purchases the drug, keeps title and sets its price.[1] |
| Reports and auditable records | Owns | Runs | Supports | The covered entity must have sufficient records, or direct access to records, to provide a complete audit trail.[1][2] |
| Internal and independent audits of contract pharmacies | Owns | Supports | Supports | HRSA expects annual independent audits; its FAQ also points to quarterly internal reviews.[1][4] |
| Self-disclosure, corrective action and manufacturer repayment | Owns | Supports | — | The covered entity notifies HRSA, fixes the problem, and contacts affected manufacturers about repayment.[1][3] |
What you can hand off, and what stays with you
A TPA can do the work
- +Running claims through your eligibility rules every day
- +Keeping accumulators and placing replenishment orders
- +Applying Medicaid Exclusion File and carve-out settings to claims
- +Producing claim-level, financial and audit-ready reports
- +Flagging exceptions and errors for your team to review
- +Pulling the data an auditor asks for, fast
The accountability stays with you
- •The legal duty to prevent diversion and duplicate discounts
- •Defining who is a patient of your entity, and your policies and procedures
- •Signing annual recertification and keeping OPAIS accurate
- •Deciding to self-disclose and approving the corrective action plan
- •Repaying manufacturers when a violation is found
- •Overseeing the TPA and every contract pharmacy
GAO recommended in 2018 that HRSA give more specific guidance on the scope and frequency of contract pharmacy oversight; GAO still lists that recommendation as open.[5]
What happens, and who handles each step
- 1
You (or your TPA) find a problem
HRSA’s guidance says to take immediate remedial action and notify HRSA of the problem and the fix. HRSA runs a self-disclosure process for exactly this.[1][3][4]
- 2
An auditor finds it first
HRSA’s audits are of covered entities and manufacturers, not TPAs. Its procedures test internal controls and compliance at the entity, its sites and its contract pharmacies, using your transaction records.[3]
- 3
Final report and CAP
You have 30 calendar days to respond to a final report. If you agree, a corrective action plan is due within 60 days; failing to submit one can lead to removal.[3]
- 4
Repayment
HRSA expects the CAP and manufacturer settlements done within six months of CAP approval. The covered entity identifies and contacts every affected manufacturer.[2][3]
- 5
Repeat findings
The same finding on re-audit can mean more audits. Diversion found in two or more audits may be treated as systematic and egregious, and knowing and intentional.[2][3]
For the full audit process, see how to prepare for a HRSA 340B audit with your TPA.
Six terms that let you carry the responsibility
You can’t contract the duty away, but you can make sure you have what you need to meet it.
Direct access to your data
Claim-level detail and history you can pull yourself, so you always have the audit trail HRSA expects you to hold.[1]
Your rules, documented
Every eligibility setting traced back to your policies, with a log of who changed what and when.[1]
Audit cooperation
A commitment to produce data and explain the logic for a HRSA or manufacturer audit within the audit’s timelines.[3]
Error correction
How the TPA tells you about a mistake, how fast it fixes it, and how it helps you size the impact for a self-disclosure or repayment.[3]
HIPAA business associate agreement
A TPA that handles patient claims data on your behalf is generally a HIPAA business associate, so a BAA should be in place.[6]
Records after you leave
A clean export of historical claims if you switch, so past years stay auditable.[1]
Comparing vendors? Use our 340B TPA comparison and see what reporting a 340B TPA should provide.
A TPA built so you can see and prove your compliance
Audit-ready claims
Claim-level detail, duplicate discount monitoring and Good Faith Inquiry tracking, so the records HRSA expects you to hold are ready when an auditor asks.
A team that answers to you
A dedicated account manager and portal access for your team. We run contract pharmacy and split billing for 300 covered entities, 24 of them hospitals.
No end-of-month true-ups
Real-time claim capture and purchase splitting mean fewer surprises in the numbers you sign off on. See how accumulators and split billing work.
Ready for 2027 rebates
The rebate module is Included for Aventi TPA clients, with real-time 340B ESP and Truzo (Kalderos) integration. Learn about the 2027 340B rebate model.
340B compliance responsibility: common questions
Sources
- Federal Register, Notice Regarding 340B Drug Pricing Program—Contract Pharmacy Services, 75 FR 10272 (Mar. 5, 2010), comment responses, essential elements (a)–(j), ongoing responsibility and certification sections — https://www.federalregister.gov/documents/2010/03/05/2010-4755/notice-regarding-340b-drug-pricing-program-contract-pharmacy-services
- 42 U.S.C. § 256b(a)(5)(A)–(D) (duplicate discounts, diversion, auditing, liability to manufacturers) and (d)(2)(B)(v) (sanctions) (Cornell LII) — https://www.law.cornell.edu/uscode/text/42/256b
- HRSA Office of Pharmacy Affairs, Program Integrity (audit scope and procedures, final report, CAP, repayment, re-audits, recertification, self-disclosure) — https://www.hrsa.gov/opa/program-integrity
- HRSA FAQ, What are the audit and compliance parameters under the contract pharmacy guidelines? — https://www.hrsa.gov/about/faqs/what-are-audit-compliance-parameters-under-contract-pharmacy-guidelines
- U.S. GAO, Drug Discount Program: Federal Oversight of Compliance at 340B Contract Pharmacies Needs Improvement, GAO-18-480 (June 2018), Recommendation 7 status — https://www.gao.gov/products/gao-18-480
- HHS Office for Civil Rights, Business Associates Frequently Asked Questions (HIPAA) — https://www.hhs.gov/hipaa/for-professionals/privacy/guidance/business-associates/index.html
Last updated November 18, 2026. This page is general information, not legal advice. Check HRSA’s current guidance and your own counsel for your program.